NCT03372317 · RECRUITING

Tau PET in Imaging and Cognition: Healthy Adults From 55-90

This study uses a brain scan tracer called 18F-MK-6240 to look for tau, a protein that builds up in Alzheimer's, in healthy older adults and people with mild cognitive impairment. Researchers will compare tau levels with memory tests and brain activity scans. The phase is unspecified. It is an imaging study, not a test of a treatment.

You may qualify if

  • Aged 55-90
  • Previously received an amyloid PET scan
  • Residing near Columbia University Medical Center
  • Must be willing and able to participate

You're excluded if

  • Have a contraindication to PET (e.g, metallic implants, pacemaker, claustrophobia, or cannot lie flat for one hour)
  • Pregnancy
  • Lactating Women
  • Current, past, or anticipated exposure to radiation
  • Significant active physical illness

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-11

View full record on ClinicalTrials.gov

All APOE4 clinical trials